ישראל -
עברית -
Ministry of Health
מוזוביל
sanofi - aventis israel ltd - plerixafor 24 mg / 1.2 ml - solution for injection - plerixafor - mozobil is indicated in combination with g-csf to enhance mobilisation of haematopietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma .
ישראל -
עברית -
Ministry of Health
מוזוביל
sanofi israel ltd - plerixafor - תמיסה להזרקה - plerixafor 24 mg / 1.2 ml - plerixafor